MRNA FUND II LP 4
4 · SIRNA THERAPEUTICS INC · Filed Nov 21, 2003
Insider Transaction Report
Form 4
MRNA FUND II LP
10% Owner
Transactions
- Sale
Common Stock
2003-11-20$6.06/sh−5$30→ 37,810 total - Sale
Common Stock
2003-11-20$6.06/sh−495$3,001→ 3,768,242 total(indirect: By Oxford Bioscience Partners IV L.P.)
Footnotes (1)
- [F1]The reporting person shares a common general partner with the partnership that owns the reported securities. The reporting person disclaims beneficial ownership of the reported securities.